Cardinal Health (NYSE:CAH) Announces FY 2027 Earnings Guidance

Cardinal Health (NYSE:CAH) issued an update on its FY 2027 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 12.400-12.600 for the period, compared to the consensus earnings per share estimate of 12.560. The company issued revenue guidance of -.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Royal Bank Of Canada initiated coverage on Cardinal Health in a research note on Wednesday, August 19th. They set an “outperform” rating and a $276.00 target price on the stock. JPMorgan Chase & Co. increased their price target on Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Morgan Stanley lifted their price objective on shares of Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Finally, UBS Group increased their price target on Cardinal Health from $274.00 to $280.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Sixteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $266.56.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $228.78 on Friday. The firm has a market capitalization of $52.98 billion, a PE ratio of 31.64, a P/E/G ratio of 1.38 and a beta of 0.50. Cardinal Health has a 1 year low of $150.77 and a 1 year high of $258.30. The business’s 50 day moving average price is $233.02 and its 200-day moving average price is $220.09.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The business had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, analysts expect that Cardinal Health will post 12.55 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the sale, the chief executive officer owned 77,901 shares of the company’s stock, valued at approximately $18,341,790.45. The trade was a 8.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Mary C. Scherer sold 2,302 shares of Cardinal Health stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total transaction of $546,471.78. Following the sale, the chief accounting officer owned 2,811 shares of the company’s stock, valued at approximately $667,303.29. The trade was a 45.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 210,271 shares of company stock valued at $49,626,657 over the last quarter. 0.12% of the stock is owned by corporate insiders.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health signed a binding letter of intent to continue its existing distribution services for CVS Health through 2032. The extension provides longer-term revenue visibility without requiring a change to the current scope of services. Cardinal Health CVS distribution agreement
• Positive Sentiment: CVS Health was identified as Cardinal Health’s only customer representing at least 10% of fiscal 2026 revenue or gross trade receivables, making the renewal particularly important for protecting future sales and earnings visibility. Cardinal Health CVS deal and outlook
• Positive Sentiment: Management reaffirmed fiscal 2027 adjusted EPS guidance of $12.40 to $12.60, broadly in line with the approximately $12.56 analyst consensus, as well as its long-term adjusted EPS growth target of 12% to 14%. The absence of a guidance cut supports confidence in the outlook. Cardinal Health and McKesson CVS agreements
• Neutral Sentiment: Cardinal Health plans to report fiscal 2027 first-quarter results before the market opens on November 5, giving investors a forthcoming catalyst to assess prescription volumes, margins and the impact of the renewed CVS relationship. Cardinal Health first-quarter earnings date
• Negative Sentiment: Separate tracking data shows substantial insider selling over the past six months, with no reported insider purchases. While these transactions may reflect planned diversification rather than a change in fundamentals, they could temper enthusiasm around the shares.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.